CFTR Modulators in Pregnancy and Postpartum

Region Stockholm

Status: Enrolling

Conditions: Cystic Fibrosis

Study type: Observational

Funder types: Other

Identifiers

NCT06302270

K2024-0507

Details and patient eligibility

About

Observational study on women with Cystic Fibrosis treated with CFTR modulators during pregnancy and postpartum and their children. Registration on maternal health parameters and effects of CFTR-modulators in the newborn infant as well as effects of exposure through mother's own milk.

Enrollment: 75 estimated patients

Sex: All

Ages: Under 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Woman with cystic fibrosis who is pregnant and treated with Kaftrio. Newborn infant to the above mentioned woman

Exclusion criteria

none

Trial design

75 participants in 1 patient group

mother-infant dyads